Korean-American med-tech company NEOFECT has officially begun trading on the KOSDAQ, securing more than $17 million in funding. A member company of the K-ICT Born2Global Centre, NEOFECT closed at 7,830 won on Nov. 29, up 130 won from 7,700 won on the first day of trading. The company had been valued